Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · IEX Real-Time Price · USD
0.471
-0.014 (-2.89%)
May 17, 2024, 4:00 PM EDT - Market closed
Tivic Health Systems Revenue
Tivic Health Systems had revenue of $1.13M in the twelve months ending March 31, 2024, down -36.61% year-over-year. Revenue in the quarter ending March 31, 2024 was $334.00K, a -11.17% decrease year-over-year. In the year 2023, Tivic Health Systems had annual revenue of $1.18M, a decrease of -36.09%.
Revenue (ttm)
$1.13M
Revenue Growth
-36.61%
P/S Ratio
0.61
Revenue / Employee
$126,000
Employees
9
Market Cap
695.54K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
Dec 31, 2020 | 860.00K | 440.00K | 104.76% |
Dec 31, 2019 | 420.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sunshine Biopharma | 24.09M |
Akanda | 2.16M |
Aethlon Medical | 574.25K |
Biodexa Pharmaceuticals | 482.28K |
China SXT Pharmaceuticals | 29.92K |
TIVC News
- 3 days ago - Tivic Reports First Quarter 2024 Financial Results and Subsequent Events - Business Wire
- 5 days ago - Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast - Business Wire
- 5 days ago - Tivic Health Announces Closing of $4.0 Million Public Offering - Business Wire
- 9 days ago - Tivic Health Announces Pricing of $4.0 Million Public Offering - Business Wire
- 10 days ago - Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems - Business Wire
- 7 weeks ago - Tivic Reports Fiscal Year 2023 Financial Results - Business Wire
- 2 months ago - Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast - Business Wire
- 3 months ago - Tivic Health Announces Completion of Enrollment for Study of Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation - Business Wire